Category: Consultants’ blog

MRI before biopsy for prostate cancer: agreed. But which technology? BPC surgeon Alan Doherty reflects on key developments at the annual conference for urologists.

By Alan Doherty, consultant urologist and founder of the Birmingham Prostate Clinic The annual meeting of the British Association of Urological Surgeons always provides a valuable bellwether for key developments in prostate cancer. I attended this year’s meeting in Liverpool at the end of June and one theme particularly stood out: the use of MRI […]

Read more

Keith Padbury’s experience of the PCA3 test, a new genetics based assessment of prostate cancer risk

Keith Padbury was one of the first patients to have a PCA3 test, a new genetics based assessment of prostate cancer risk five years ago. He has benefitted from advanced assessments which mean unnecessary biopsies are avoided. Keith describes his own experience and how an elevated PSA result does not inevitably lead to a biopsy […]

Read more

What I have learnt from my experience of the UroLift procedure

By Maya Harris, consultant urologist, Birmingham Prostate Clinic I first came across this new procedure in America four years ago, whilst attending a meeting of the American Urological Association. I was surprised by the simplicity and elegance of the idea that rather than removing the prostate tissue, it could be retracted to open the passage […]

Read more

How reliable is the PCA3 test for prostate cancer?

How reliable is the PCA3 test for prostate cancer? What we have learnt from undertaking 688 tests By Alan Doherty Back in 2007, we were one of the first clinics in the UK to introduce a new type of test for prostate cancer. This test was based on the discovery that very high levels of […]

Read more

GP Questions: Raised PSA and Prostate Cancer

The main question for GPs: raised PSA and prostate cancer By Alan Doherty, consultant urologist, Birmingham Prostate Clinic I am pleased to have another opportunity to meet GPs for an educational event on November 17. I attend these events as often as possible, because we need effective connections between the GP surgery and hospital. Meeting […]

Read more

What is the new UroLift for benign prostatic hyperplasia?

Earlier this year, a new approach to benign prostatic hyperplasia (BPH) received approval for use in the NHS. The new approach is called UroLift and is designed to alleviate the symptoms of BPH without cutting or vaporising the surplus prostate tissue. To understand this new treatment, we need to start by looking at what happens […]

Read more

How to choose between different types of prostate cancer surgery?

I frequently see patients who have been diagnosed with prostate cancer, have decided on surgery, but are struggling with the choice of different types of surgery. Increasingly, there can be a choice, especially if patients seek opinions from two or three different urologists (which we certainly support). A common scenario might be: the patient sees […]

Read more